New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Orchestra Therapeutics Inc.
Division of Immune Response BioPharma Inc.
www.imnr.com
Latest From Orchestra Therapeutics Inc.
Can Big Pharma Save Biotech Investors?
All the biotech stock indices are down; record numbers of companies are selling at lower-than-cash valuations. Investors want Pharma to step up and buy, removing inventory from the market, and spreading limited investment dollars over a smaller set of opportunities. While buyers say they aren't going to radically change their strategies simply to take advantage of cheap prices, it's clear that more deals will get signed - mostly because more sellers will accept terms they once would have rejected. . In short, a hotter dealmaking climate will keep biotech healthy enough to survive as an industry, albeit a smaller one, and, perhaps, with a slightly lower ceiling on returns.
Tracking Agouron
Despite growing sales of {Viracept}, Agouron's stock is in the doldrums. It needs a follow-on product, but doesn't have any great near-term prospects of its own and can't spend the research funds necessary to develop earlier ones without hurting earnings. Agouron is therefore turning to licensing later-stage drugs and simultaneously remaking its share structure with tracking stocks. Its idea is to sequester R&D spending into a separately traded cancer company and thereby spare the income statement of Agouron-Viracept.
Asian AIDS Markets: Growing Opportunities
With the world' s second largest concentration of HIV patients (after Africa), Southeast Asia is a booming market for AIDS products. Government initiatives to prevent and combat the spread of this virus present opportunities for Western companies in both diagnostic and therapeutic products.
Company Information
- Industry
-
Biotechnology
- Gene Therapy, Cell Therapy
-
Pharmaceuticals
- Drug Delivery
- Vaccines
- Therapeutic Areas
- Immune Disorders
- Infectious & Viral Diseases
- Alias(es)
- Immune Response Corp.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Immune Response BioPharma Inc.
- Senior Management
- Joseph F O'Neill, Pres. & CEO
- Contact Info
-
Orchestra Therapeutics Inc.
Phone: (760) 431-7080
5935 Darwin Court
Carlsbad, CA 92008-7399
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Orchestra Therapeutics Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice